Compile Data Set for Download or QSAR
maximum 50k data
Found 15 Enz. Inhib. hit(s) with all data for entry = 11669
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi:  39.9nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi:  39.9nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi:  39.9nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >8.62E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >8.62E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >8.62E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >9.15E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >9.15E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >9.15E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >9.60E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >9.60E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >9.60E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >9.86E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >9.86E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM311911(US10166214, Example 47 | US10675268, Example 47 | ...)
Affinity DataKi: >9.86E+3nMAssay Description:The displacement of the labeled ligand by the test compound leads to a decreased signal. For the binding experiments 200 μL of membrane homogena...More data for this Ligand-Target Pair
In DepthDetails US Patent